Nazlı DİZEN NAMDAR, Deniz Bahar AKGÜN KARAPINAR, Esra KURAL ÜNÜVAR

Evaluation of cutaneous anthrax cases during an outbreak in the east region of Turkey

Background/aim: Anthrax is a zoonotic infection caused by Bacillus anthracis. We aimed to retrospectively evaluate cutaneous anthrax cases that occurred during an outbreak in eastern Turkey (Hakkari-Yüksekova), where people mostly earn their living from animal husbandry. Materials and methods: Forty-six cutaneous anthrax patients that were admitted to the hospital during a very short duration of 3 months (June August 2011) were evaluated. Results: Out of 46 patients, 27 (52%) were women and 19 (48%) were men. The mean age was 37 ± 13 years. The distribution of occupations was 1 butcher, 1 cook, 5 farmers, 27 housewives, 11 shepherds, and 1 teacher. Multiple lesions were seen in 7 patients (15%) and the rest of the patients had only 1 lesion. We observed significant clinical differences among the cases and noted which particular symptoms were associated with the various skin lesions. We treated our patients with intramuscular procaine penicillin or oral ciprofloxacin/doxycycline. Conclusion: Anthrax is an important health problem that can cause lethal outbreaks. Therefore, one should think about anthrax when faced with a patient with history of animal contact that has a painless ulcer with edema and/or vesicles, especially in endemic countries like Turkey.

PDF

___

1. Turnbull PCB, Kramer JM. Bacillus. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ, editors. 5th ed. Manual of Clinical Microbiology. Washington, DC, USA: ASM Press; 1991. pp. 296-303.
2. Little SF, Ivins BE. Molecular pathogenesis of Bacillus anthracis infection. Microbes Infect 1999; 1: 131-139.
3. Turnbull P. Anthrax in Humans and Animals. 4th ed. Geneva, Switzerland: WHO Press; 2008.
4. Doğanay M, Almaç A, Hanağasi R. Primary throat anthrax. A report of six cases. Scand J Infect Dis 1986; 18: 415-419.
5. Thappa DM, Karthikeyan K. Anthrax: an overview within the Indian subcontinent. Int J Dermatol 2001; 40: 216-222.
6. Wenner KA, Kenner JR. Anthrax. Dermatol Clin 2004; 22: 247- 256.
7. Kaya A, Tasyaran MA, Erol S, Ozkurt Z, Ozkan B. Anthrax in adults and children: a review of 132 cases in Turkey. Eur J Clin Microbiol Infect Dis 2002; 21: 258-261.
8. Karahocagil MK, Akdeniz N, Akdeniz H, Calka O, Karsen H, Bilici A, Bilgili SG, Evirgen O. Cutaneous anthrax in eastern Turkey: a review of 85 cases. Clin Exp Dermatol 2008; 33: 406- 411.
9. Doğanay M, Kökkaya A, Hah MN. A review of 35 anthrax cases. Mikrobiyoloji Bülteni 1983; 17: 1-10 (article in Turkish with a summary in English).
10. Oncül O, Ozsoy MF, Gul HC, Koçak N, Cavuslu S, Pahsa A. Cutaneous anthrax in Turkey: a review of 32 cases. Scand J Infect Dis 2002; 34: 413-416.
11. Engin A, Elaldı N, Dökmetaş İ, Bakıcı MZ, Kaya Ş, Bakır M. Cutaneous anthrax in the central Anatolia region of Turkey: a review of 39 adults cases. Türkiye Klinikleri J Med Sci 2010; 30: 1032-1038.
12. Baykam N, Ergonul O, Ulu A, Eren S, Celikbas A, Eroglu M, Dokuzoguz B. Characteristics of cutaneous anthrax in Turkey. J Infect Dev Ctries 2009; 3: 599-603.
13. Demirdag K, Ozden M, Saral Y, Kalkan A, Kilic SS, Ozdarendeli A. Cutaneous anthrax in adults: a review of 25 cases in the eastern Anatolian region of Turkey. Infection 2003; 31: 327- 330.
14. Metan G, Doğanay M. The antimicrobial susceptibility of Bacillus anthracis isolated from human cases: a review of the Turkish literature. Türkiye Klinikleri J Med Sci 2009; 29: 229- 235.
15. Doganay M, Metan G, Alp E. A review of cutaneous anthrax and its outcome. J Infect Public Health 2010; 3: 98-105.
16. Bossi P, Tegnell A, Baka A, Van Loock F, Hendriks J, Werner A, Maidhof H, Gouvras G. Bichat guidelines for the clinical management of anthrax and bioterrorism-related anthrax. Euro Surveill 2004; 9: 1-7.
17. Stern EJ, Uhde KB, Shadomy SV, Messonnier N. Conference report on public health and clinical guidelines for anthrax. Emerg Infect Dis 2008; 14: e1.
18. Ray TK, Hutin YJ, Murhekar MV. Cutaneous anthrax, West Bengal, India, 2007. Emerg Infect Dis 2009; 15: 497-499.
19. Woods CW, Ospanov K, Myrzabekov A, Favorov M, Plikaytis B, Ashford DA. Risk factors for human anthrax among contacts of anthrax-infected livestock in Kazakhstan. Am J Trop Med Hyg 2004; 71: 48-52.
20. Turnbull PCB, Böhm R, Cosivi O, Doganay M, Hugh-Jones ME, Joshi DD, Lalitha MK, de Vos V. Guidelines for the Surveillance and Control of Anthrax in Human and Animals. 3rd ed. WHO/EMC/ZDI/98/6.
21. Rao GR, Padmaja J, Lalitha MK, Rao PV, Gopal KV, Kumar HK, Mohanraj P. An outbreak of cutaneous anthrax in a nonendemic district--Visakhapatnam in Andhra Pradesh. Indian J Dermatol Venereol Leprol 2005; 71: 102-105.
22. Chakraborty A, Khan SU, Hasnat MA, Parveen S, Islam MS, Mikolon A, Chakraborty RK, Ahmed BN, Ara K, Haider N et al. Anthrax outbreaks in Bangladesh, 2009-2010. Am J Trop Med Hyg 2012; 86: 703-710.
23. Reddy R, Parasadini G, Rao P, Uthappa CK, Murhekar MV. Outbreak of cutaneous anthrax in Musalimadugu village, Chittoor district, Andhra Pradesh, India, July-August 2011. J Infect Dev Ctries 2012; 6: 695-699.
24. Rao GRR, Padmaja J, Lalitha MK, Rao PVK, Kumar HK, Gopal KVT, Jaideep M, Mohanraj P. Cutaneous anthrax in a remote tribal areaAraku Valley, Visakhapatnam district, Andhra Pradesh, southern India. Int J Dermatol 2007; 46: 55-58.